News
Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.
COPD has a large economic impact on the healthcare system and a destructive impact on the lives of patients and their ...
Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...
Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...
Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung ...
Investigators concluded that individuals with comorbidities experienced higher risks of severe COVID-19 outcomes during the ...
In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.
Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...
Pulmonary Drug Delivery System Market Size to Worth USD 73.14 Billion by 2031 | The Insight Partners
According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results